Refractory Cholangiocarcinoma
specificA cholangiocarcinoma that is resistant to treatment.
7
Centers
7
Active Trials
—
Cancer Funding
Top Centers for Refractory Cholangiocarcinoma(7)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive Active Research Program | 57.1 |
| 2 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 57.1 |
| 3 | NCI Comprehensive Active Research Program | 57.1 |
| 4 | UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program | 57.1 |
| 5 | University of Illinois Cancer CenterChicago, IL Active Research Program | 57.1 |
| 6 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 57.1 |
| 7 | Cancer Center at IllinoisUrbana, IL Active Research Program | 57.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →